✦ LIBER ✦

Second cancer following 131-I therapy in patients with differentiated thyroid carcinoma

✍ Scribed by D. Casara; G. Saladini; R. Mazzarotto; D. Rubello

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dosimetry-guided high-activity131I thera

✍ Frederik A. Verburg; Heribert Hänscheid; Johannes Biko; Maria C. Hategan; Michae 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 211 KB

131I therapy in differentiated thyroid c

✍ Yugal K. Maheshwari; C. Stratton Hill Jr.; Thomas P. Haynie III.; Robert C. Hick 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

The value of detectable thyroglobulin in

✍ D. van Dijk; J. T. M. Plukker; A. N. A. van der Horst-Schrivers; L. Jansen; A. H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

131I gastric uptake with and without ome

✍ Castro, Gabriel; Berrocal, Isabel; Carmona, Jaime; González, Javiera; González, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 80 KB

The influence of I-131 therapy on FDG up

✍ Guang-Uei Hung; Kwo-Whei Lee; Pei-Yung Liao; Li-Heng Yang; Kwang-Tao Yang 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 225 KB

Are there disadvantages in administering

✍ Massimo Salvatori; Germano Perotti; Vittoria Rufini; Maria Lodovica Maussier; Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB